COVID-19 Registry Aims To Map And Address Potential Test Shortages

Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.

glowing city and human population density areas with bouncy line connections between them. view of america. suitable for technology, future and science themes. 3d illustration

Top medtech companies – including Abbott Diagnostics, Roche Molecular Diagnostics, Siemens AG and Thermo Fisher Scientific – have teamed up to share information on COVID-19 diagnostic tests on a registry. The aim is to use the information to get an accurate picture of how testing is happening and mitigate any testing shortage.

Medtech industry group AdvaMed announced on 21 July that it launched the national COVID-19 diagnostic supply registry, which also includes participation by BD Diagnostics - Diagnostic Systems, bioMerieux...

More from Business

More from Medtech Insight